XANTIPPE
ActiveSummary
XANTIPPE has been active since 1981 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.2m and a net result of €299,289. Equity is growing by about 4.5% per year across the filed financial years. Its solvency ranks better than 87% of 1,364 sector peers (NACE 96, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
23-01
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
30-06
Financial
Highest result from 2019 to 2025net €299,289 ▲10.5%
Net result €299,289, the highest in the series.
17-01
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
30-01
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
2023
10-01
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format
2022
30-06
Financial
Equity above €2mequity €2.0m ▲2.1%
A profit in every financial year since 2019 builds equity to €2.0m.
2021
06-12
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
2020
07-12
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format
30-06
Financial
Weakest financial yearnet €134,092 ▼38.7%
Net result drops to €134,092, the lowest in the series; recovery starts the following year.
16-01
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format
2019
17-01
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format
2018
12-01
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format
2017
18-01
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 44 annual accounts filed, the latest 10 are here; all 44 are under Financials.
0 of 7 deeds read
About the unread acts
We know of 7 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.